




Searching News Database: HPV test
HSMN NewsFeed - 17 Dec 2021
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
HSMN NewsFeed - 25 Aug 2021
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
HSMN NewsFeed - 25 Apr 2018
FDA Approval of ThinPrep(R) Integrated Imager Expands Automated Imaging for Pap Testing to More Labs
FDA Approval of ThinPrep(R) Integrated Imager Expands Automated Imaging for Pap Testing to More Labs
HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
HSMN NewsFeed - 25 Jul 2014
Guided Therapeutics Files PMA Amendment with FDA for LuViva(R) Advanced Cervical Scan
Guided Therapeutics Files PMA Amendment with FDA for LuViva(R) Advanced Cervical Scan
HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
HSMN NewsFeed - 16 Oct 2012
Hologic Announces FDA Approval of APTIMA HPV 16 18/45 Genotype Assay for Use on the TIGRIS System
Hologic Announces FDA Approval of APTIMA HPV 16 18/45 Genotype Assay for Use on the TIGRIS System
HSMN NewsFeed - 25 Jul 2012
Guided Therapeutics and FDA Agree on Plan for LuViva(R) Advanced Cervical Scan PMA
Guided Therapeutics and FDA Agree on Plan for LuViva(R) Advanced Cervical Scan PMA
HSMN NewsFeed - 18 Jul 2012
Guided Therapeutics Notified of CE Mark Approval for LuViva(R) Advanced Cervical Scan
Guided Therapeutics Notified of CE Mark Approval for LuViva(R) Advanced Cervical Scan
HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
HSMN NewsFeed - 31 Oct 2011
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
HSMN NewsFeed - 7 Mar 2011
Guided Therapeutics Provides Update on FDA PMA Review of Cervical Cancer Test
Guided Therapeutics Provides Update on FDA PMA Review of Cervical Cancer Test
HSMN NewsFeed - 2 Dec 2010
FDA Accepts Guided Therapeutics' Non-Invasive Cervical Cancer Scanner PMA Application for Review
FDA Accepts Guided Therapeutics' Non-Invasive Cervical Cancer Scanner PMA Application for Review
HSMN NewsFeed - 27 Sep 2010
Guided Therapeutics Files Premarket Approval Application for Non-Invasive Cervical Cancer Scanner with FDA
Guided Therapeutics Files Premarket Approval Application for Non-Invasive Cervical Cancer Scanner with FDA
HSMN NewsFeed - 28 Apr 2010
Konica Minolta Opto, Inc. Extends Product Development Licensing Agreement with Guided Therapeutics
Konica Minolta Opto, Inc. Extends Product Development Licensing Agreement with Guided Therapeutics
HSMN NewsFeed - 10 Feb 2009
Guided Therapeutics, Inc. Reports Preliminary Findings from FDA Pivotal Clinical Trial
Guided Therapeutics, Inc. Reports Preliminary Findings from FDA Pivotal Clinical Trial
HSMN NewsFeed - 26 Jan 2009
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
HSMN NewsFeed - 13 Jan 2009
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection
HSMN NewsFeed - 30 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
HSMN NewsFeed - 28 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
HSMN NewsFeed - 20 May 2008
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection from Cervical Disease than the Pap
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection from Cervical Disease than the Pap
HSMN NewsFeed - 30 Oct 2007
New Painless Test for Cervical Cancer Could Provide Access to Better Healthcare for Women Worldwide
New Painless Test for Cervical Cancer Could Provide Access to Better Healthcare for Women Worldwide
HSMN NewsFeed - 24 Sep 2007
Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
HSMN NewsFeed - 19 Jun 2007
Beckman Coulter, Inc. Dismissed in Case Against Ventana Medical Systems, Inc.
Beckman Coulter, Inc. Dismissed in Case Against Ventana Medical Systems, Inc.
HSMN NewsFeed - 3 Jun 2007
QIAGEN and Digene Announce Merger Creating Market and Technology Leader In Molecular Diagnostics
QIAGEN and Digene Announce Merger Creating Market and Technology Leader In Molecular Diagnostics
HSMN NewsFeed - 10 May 2007
Preliminary Injunction Denied in Digene's Case Against Ventana Medical Systems
Preliminary Injunction Denied in Digene's Case Against Ventana Medical Systems
HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
HSMN NewsFeed - 15 Mar 2007
SpectRx, Inc. Announces Planned Reorganization; Focus on Cervical Cancer Detection
SpectRx, Inc. Announces Planned Reorganization; Focus on Cervical Cancer Detection
HSMN NewsFeed - 30 Jan 2007
SpectRx, Inc. Holds Pre-PMA Meetings with FDA on Painless Cervical Cancer Test
SpectRx, Inc. Holds Pre-PMA Meetings with FDA on Painless Cervical Cancer Test
HSMN NewsFeed - 17 Jan 2007
bioMerieux Licenses Technology From Norchip to Launch a HPV Test For Cervical Cancer Risk Detection
bioMerieux Licenses Technology From Norchip to Launch a HPV Test For Cervical Cancer Risk Detection
HSMN NewsFeed - 14 Nov 2006
Daryl J. Faulkner Appointed Chief Executive Officer and Director of Digene
Daryl J. Faulkner Appointed Chief Executive Officer and Director of Digene
HSMN NewsFeed - 27 Oct 2006
James Godsey, Ph.D., to Join Digene as Senior Vice President Research and Development
James Godsey, Ph.D., to Join Digene as Senior Vice President Research and Development
HSMN NewsFeed - 28 Sep 2006
California to Require Insurers to Cover HPV Testing in Cervical Cancer Screening
California to Require Insurers to Cover HPV Testing in Cervical Cancer Screening
HSMN NewsFeed - 23 Aug 2006
Charles M. Fleischman Resigns as Digene President, COO and Chief Financial Officer
Charles M. Fleischman Resigns as Digene President, COO and Chief Financial Officer
Additional items found! 33

Members Archive contains
33 additional stories matching:
HPV test
(Password required)
HPV test
(Password required)